Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/23833Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | - |
| dc.contributor.author | HALPERN, B. | - |
| dc.contributor.author | FARIA, A. M. | - |
| dc.contributor.author | HALPERN, A. | - |
| dc.date.accessioned | 2017-11-27T16:39:46Z | - |
| dc.date.available | 2017-11-27T16:39:46Z | - |
| dc.date.issued | 2011 | - |
| dc.identifier.citation | DRUGS OF TODAY, v.47, n.8, p.575-581, 2011 | - |
| dc.identifier.issn | 1699-3993 | - |
| dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/23833 | - |
| dc.description.abstract | The combination of bupropion and naltrexone is one of the most promising new possibilities for the treatment of obesity in an era of increasing prevalence of this disease and decreasing options for its pharmacological management. Although approved by FDA panel members, it was temporally rejected by the FDA afterwards, who demanded more cardiovascular safety data for its commercialization. This monograph will focus on the physiology involved in its mechanisms of action and results of clinical trials. | - |
| dc.language.iso | eng | - |
| dc.publisher | PROUS SCIENCE, SA-THOMSON REUTERS | - |
| dc.relation.ispartof | Drugs of Today | - |
| dc.rights | restrictedAccess | - |
| dc.subject.other | placebo-controlled trial | - |
| dc.subject.other | double-blind | - |
| dc.subject.other | weight control | - |
| dc.subject.other | heart-disease | - |
| dc.subject.other | bupropion | - |
| dc.subject.other | sibutramine | - |
| dc.subject.other | phentermine | - |
| dc.subject.other | overweight | - |
| dc.subject.other | orlistat | - |
| dc.subject.other | drugs | - |
| dc.title | BUPROPION/NALTREXONE FIXED-DOSE COMBINATION FOR THE TREATMENT OF OBESITY | - |
| dc.type | article | - |
| dc.rights.holder | Copyright PROUS SCIENCE, SA-THOMSON REUTERS | - |
| dc.identifier.doi | 10.1358/dot.2011.47.8.1617339 | - |
| dc.identifier.pmid | 21850280 | - |
| dc.subject.wos | Pharmacology & Pharmacy | - |
| dc.type.category | original article | - |
| dc.type.version | publishedVersion | - |
| hcfmusp.description.beginpage | 575 | - |
| hcfmusp.description.endpage | 581 | - |
| hcfmusp.description.issue | 8 | - |
| hcfmusp.description.volume | 47 | - |
| hcfmusp.origem | WOS | - |
| hcfmusp.origem.id | WOS:000295425600001 | - |
| hcfmusp.origem.id | 2-s2.0-80052727199 | - |
| hcfmusp.publisher.city | BARCELONA | - |
| hcfmusp.publisher.country | SPAIN | - |
| hcfmusp.relation.reference | Greenway FL, 2009, OBESITY, V17, P30, DOI 10.1038/oby.2008.461 | - |
| hcfmusp.relation.reference | Padwal R, 2009, CURR OPIN INVEST DR, V10, P1117 | - |
| hcfmusp.relation.reference | TRUANT AP, 1972, CURR THER RES CLIN E, V14, P726 | - |
| hcfmusp.relation.reference | Wright SM, 2011, NAT REV ENDOCRINOL, V7, P69, DOI 10.1038/nrendo.2010.231 | - |
| hcfmusp.relation.reference | ASCHER JA, 1995, J CLIN PSYCHIAT, V56, P395 | - |
| hcfmusp.relation.reference | Halford JCG, 2007, DRUGS, V67, P27, DOI 10.2165/00003495-200767010-00004 | - |
| hcfmusp.relation.reference | Hendricks EJ, 2009, OBESITY, V17, P1730, DOI 10.1038/oby.2009.69 | - |
| hcfmusp.relation.reference | WEINTRAUB M, 1984, ARCH INTERN MED, V144, P1143, DOI 10.1001/archinte.144.6.1143 | - |
| hcfmusp.relation.reference | Christensen R, 2007, LANCET, V370, P1706, DOI 10.1016/S0140-6736(07)61721-8 | - |
| hcfmusp.relation.reference | Wadden TA, 2011, OBESITY, V19, P110, DOI 10.1038/oby.2010.147 | - |
| hcfmusp.relation.reference | Davidson MH, 1999, JAMA-J AM MED ASSOC, V281, P235, DOI 10.1001/jama.281.3.235 | - |
| hcfmusp.relation.reference | Woods SC, 2008, J CLIN ENDOCR METAB, V93, pS37, DOI 10.1210/jc.2008-1630 | - |
| hcfmusp.relation.reference | Yanovski SZ, 2002, NEW ENGL J MED, V346, P591 | - |
| hcfmusp.relation.reference | Greenway FL, 2009, J CLIN ENDOCR METAB, V94, P4898, DOI 10.1210/jc.2009-1350 | - |
| hcfmusp.relation.reference | James WPT, 2010, NEW ENGL J MED, V363, P905, DOI 10.1056/NEJMoa1003114 | - |
| hcfmusp.relation.reference | Greenway FL, 2010, LANCET, V376, P595, DOI 10.1016/S0140-6736(10)60888-4 | - |
| hcfmusp.relation.reference | Anderson JW, 2002, OBES RES, V10, P633, DOI 10.1038/oby.2002.86 | - |
| hcfmusp.relation.reference | Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423 | - |
| hcfmusp.relation.reference | de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367 | - |
| hcfmusp.relation.reference | *CLINICALTRIALS, NCT00567255 CLINICAL | - |
| hcfmusp.relation.reference | *CLINICALTRIALS, NCT00563563 CLINICAL | - |
| hcfmusp.relation.reference | *CLINICALTRIALS, NCT00624858 CLINICAL | - |
| hcfmusp.relation.reference | *CLINICALTRIALS, NCT00711477 CLINICAL | - |
| hcfmusp.relation.reference | Connolly HM, 1997, NEW ENGL J MED, V337, P581, DOI 10.1056/NEJM199708283370901 | - |
| hcfmusp.relation.reference | Dvorak RV, 2010, OBES REV, V11, P833, DOI 10.1111/j.1467-789X.2010.00828.x | - |
| hcfmusp.relation.reference | Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028 | - |
| hcfmusp.relation.reference | Food and Drug Administration, 2010, MER SIB MARK WITHDR | - |
| hcfmusp.relation.reference | Halpern B., 2010, Pharmaceuticals, V3, P2398, DOI 10.3390/ph3082398 | - |
| hcfmusp.relation.reference | HOLLANDER P, 2010, 70 ANN M SCI SESS AM | - |
| hcfmusp.relation.reference | HOLTZMAN SG, 1979, LIFE SCI, V24, P219, DOI 10.1016/0024-3205(79)90222-4 | - |
| hcfmusp.relation.reference | Lee MW, 2009, EXPERT OPIN PHARMACO, V10, P1841, DOI 10.1517/14656560903048959 | - |
| hcfmusp.relation.reference | Mansur AD, 2010, CLINICS, V65, P1143, DOI 10.1590/S1807-59322010001100016 | - |
| hcfmusp.relation.reference | *MERCK MAN HLTH CA, 2011, BUPR | - |
| hcfmusp.relation.reference | *OR THER INC, CONTR R | - |
| hcfmusp.relation.reference | *OR THER INC, EMP TM | - |
| hcfmusp.relation.reference | Roddy E, 2004, BRIT MED J, V328, P509, DOI 10.1136/bmj.328.7438.509 | - |
| hcfmusp.relation.reference | Sari R, 2004, ENDOCR RES, V30, P159, DOI 10.1081/ERC-200027356 | - |
| hcfmusp.relation.reference | Wadden TA, 2000, OBES RES, V8, P431, DOI 10.1038/oby.2000.53 | - |
| hcfmusp.relation.reference | World Health Organization, GLOB STRAT DIET PHYS | - |
| dc.description.index | MEDLINE | - |
| hcfmusp.citation.scopus | 5 | - |
| hcfmusp.scopus.lastupdate | 2024-04-12 | - |
| Appears in Collections: | Artigos e Materiais de Revistas Científicas - HC/ICHC Artigos e Materiais de Revistas Científicas - HC/ICr Artigos e Materiais de Revistas Científicas - LIM/42 | |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.